Cytotoxic 0 9 0 9 B-treatment
agents 10 16 10 16 I-treatment
, 16 17 16 17 O
unless 18 24 18 24 O
at 25 27 25 27 O
least 28 33 28 33 O
4 34 35 34 35 B-lower_bound
weeks 36 41 36 41 I-lower_bound
have 42 46 42 46 O
elapsed 47 54 47 54 O
from 55 59 55 59 O
last 60 64 60 64 O
dose 65 69 65 69 O
of 70 72 70 72 O
prior 73 78 73 78 B-treatment
anti 79 83 79 83 I-treatment
- 83 84 83 84 I-treatment
cancer 84 90 84 90 I-treatment
therapy 91 98 91 98 I-treatment
and 99 102 99 102 O
initiation 103 113 103 113 O
of 114 116 114 116 O
study 117 122 117 122 B-treatment
therapy 123 130 123 130 I-treatment

Eastern 0 7 131 138 B-clinical_variable
Cooperative 8 19 139 150 I-clinical_variable
Oncology 20 28 151 159 I-clinical_variable
Group 29 34 160 165 I-clinical_variable
Performance 35 46 166 177 I-clinical_variable
Status 47 53 178 184 I-clinical_variable
of 54 56 185 187 O
0 57 58 188 189 B-lower_bound
or 59 61 190 192 O
1 62 63 193 194 B-upper_bound

Participants 0 12 195 207 O
with 13 17 208 212 O
primary 18 25 213 220 B-cancer
CNS 26 29 221 224 I-cancer
malignancies 30 42 225 237 I-cancer
, 42 43 237 238 O
or 44 46 239 241 O
tumors 47 53 242 248 B-cancer
with 54 58 249 253 O
CNS 59 62 254 257 B-cancer
metastases 63 73 258 268 I-cancer
as 74 76 269 271 O
the 77 80 272 275 O
only 81 85 276 280 O
site 86 90 281 285 O
of 91 93 286 288 O
disease 94 101 289 296 O
, 101 102 296 297 O
will 103 107 298 302 O
be 108 110 303 305 O
excluded 111 119 306 314 O

histologic 0 10 315 325 O
or 11 13 326 328 O
cytologic 14 23 329 338 O
confirmation 24 36 339 351 O
of 37 39 352 354 O
a 40 41 355 356 O
solid 42 47 357 362 B-cancer
tumor 48 53 363 368 I-cancer
that 54 58 369 373 O
is 59 61 374 376 O
advanced 62 70 377 385 O
( 71 72 386 387 O
metastatic 72 82 387 397 O
, 82 83 397 398 O
recurrent 84 93 399 408 O
and/or 94 100 409 415 O
unresectable 101 113 416 428 O
) 113 114 428 429 O

rior 0 4 430 434 O
anti 5 9 435 439 O
- 9 10 439 440 O
cancer 10 16 440 446 O
treatments 17 27 447 457 O
such 28 32 458 462 O
as 33 35 463 465 O
chemotherapy 36 48 466 478 B-treatment
, 48 49 478 479 O
radiotherapy 50 62 480 492 B-treatment
, 62 63 492 493 O
hormonal 64 72 494 502 B-treatment
, 72 73 502 503 O
or 74 76 504 506 O
immunotherapy 77 90 507 520 B-treatment
( 91 92 521 522 O
including 92 101 522 531 O
anti 102 106 532 536 B-treatment
- 106 107 536 537 I-treatment
PD-1 107 111 537 541 I-treatment
/ 111 112 541 542 I-treatment
PD 112 114 542 544 I-treatment
- 114 115 544 545 I-treatment
L1 115 117 545 547 I-treatment
) 117 118 547 548 O
are 119 122 549 552 O
permitted 123 132 553 562 O

